GeneDX Stock Plummets, Misses Sales & Earnings Targets

About this episode

GeneDX's stock plummets after missing sales and earnings targets despite a 17% increase in sales.

GeneDXs Q1 earnings miss, sales up 17% but short of expectations, adjusted loss per share worse than forecast, full-year sales outlook cut, pricing power uncertain, stock plummets. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/472a098c74cbc459

People in this episode

Host: The Daily News Now!

Topics covered

• stock market
• earnings report
• financial analysis
• business news
• GeneDX

Keywords

• GeneDX
• stock plummet
• earnings miss
• sales targets
• financial outlook

Sponsors

Solipillow

Mentioned in this episode

Organizations: GeneDX

More episodes of Business & Finance News Today | 2 Min News | The Daily News Now!

• Axcelis Insider Sale Amid Stock Surge · June 13, 2026 · 2 min
• Bitcoin’s $100K Shot in Q4 · June 13, 2026 · 2 min
• US and Iran Edge Toward Deal · June 13, 2026 · 2 min
• Iran US Deal Set to Sign Tomorrow · June 13, 2026 · 2 min
• Trump's G7 Diplomacy with Middle East Leaders · June 13, 2026 · 2 min
• Nu Holdings Surges in Latin America · June 13, 2026 · 2 min